The risks of long-term nitrofurantoin prophylaxis in patients with recurrent urinary tract infection: A recent medico-legal case

BJU International

Volumn 103, Issue 5, 2009, Pages 567-569

  Cetti, Richard J ^a   Venn, Suzie ^a,b   Woodhouse, Christopher R J ^b  

^a ST RICHARD S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITROFURANTOIN;

BLOOD ANALYSIS; CASE REPORT; CHRONIC HEPATITIS; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; JAUNDICE; LIVER FUNCTION TEST; LONG TERM CARE; MEDICOLEGAL ASPECT; NOTE; PRESCRIPTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; URINARY TRACT INFECTION;

ANTI-INFECTIVE AGENTS, URINARY; ANTIBIOTIC PROPHYLAXIS; HUMANS; LIVER DISEASES; LUNG DISEASES; MALPRACTICE; NITROFURANTOIN; RISK FACTORS; TIME FACTORS; URINARY TRACT INFECTIONS;

EID: 60449085255     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08008.x     Document Type: Note

References (20)

1. Parker G. Failure to adequately monitor liver and lung function. MDU J 2007 23 : 24 5
2. Nicolle LE, Ronald AR. Recurrent urinary tract infection in adult women: diagnosis and treatment. Infect Dis Clin North Am 1987 1 : 793 806
3. Ludwig M, Hoyme U, Weidner W. Recurrent urinary tract infection in women. Long-term antibiotic prophylaxis. Urologe A 2006 45 : 436 42
4. Brumfitt W, Hamilton-Miller JM. A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection. Infection 1995 23 : 98 102
5. Brumfitt W, Hamilton-Miller JM. Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience. J Antimicrob Chemother 1998 42 : 363 71
6. Davey P, Steinke D, MacDonald T et al. Not so simple cystitis: how should prescribers be supported to make informed decisions about the increasing prevalence of infections caused by drug-resistant bacteria? Br J General Pract 2000 50 : 143 6
7. Magee JT, Pritchard EL, Fitzgerald KA et al. Antibiotic prescribing and antibiotic resistance in community practice: retrospective study. BMJ 1999 319 : 1239 40
8. Tu Y, McCalla DR. Effect of activated nitrofurans on DNA. Biochem Biophys Acta 1975 402 : 142 9
9. Mendez JL, Nardous HF, Hartman TE et al. Chronic nitrofurantoin-induced lung disease. Mayo Clin Proc 2005 80 : 1298 302
10. Kammire LD, Donofrio PD. Nitrofurantoin neuropathy: a forgotten adverse effect. Obstet Gynecol 2007 110 : 510 2
11. Sharp JR, Ishak KG, Zimmerman HJ. Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin. Ann Intern Med 1980 92 : 14 9
12. Coraggio MJ, Gross TP, Roscelli JD. Nitrofurantoin toxicity in children. Pediatr Infect Dis J 1989 8 : 163 6
13. Anonymous. Pulmonary toxicity with long-term nitrofurantoin. Aust Adv Drug React Bull 2004 23 : 15
14. Chudnofsky CR, Otten EJ. Acute pulmonary toxicity to nitrofurantoin. J Emerg Med 1989 7 : 15 9
15. Martindale. The Complete Drug Reference, 35th edn. Update. Online edn. Available at: http://www.medicinescomplete.com/mc/faq.htm. Accessed September 2006
16. Rosenow EC, DeRemee RA, Dines DE. Chronic nitrofurantoin pulmonary reaction. Report of 5 cases. N Engl J Med 1968 279 : 1258 62
17. Petri WA. Sulfonamides, sulfamethoxazole, quinolones and agents for urinary tract infections. In Hardman J, Linford L, The Pharmacological Basics of Therapeutics, 10th edn. Chapt 44. New York : Goodman and Gilman's, 2001 : 1185
18. Schattner A, Von der walde J, Kozak N et al. Nitrofurantoin-induced immune- mediated lung and liver disease. Am J Med Sci 1999 317 : 336 40
19. Stricker BH, Blok AP, Claas FH et al. Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases. Hepatology 1988 8 : 599 606
20. Tariff information. Confirmation of payment by results. PbR arrangements for 2008/9. Available at http://www.dh.gov.uk. Accessed February 2008